Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Williamson

Showing results (811-820 of 822) with videos related to

Pageof 83
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trialAhmad Mourad, Gregory A Grandits, Lianne K Siegel, et al.
Plos Biology|April 7, 2021
Neural stem cells traffic functional mitochondria via extracellular vesiclesLuca Peruzzotti-Jametti, Joshua D Bernstock, Cory M Willis, et al.
Elife|November 24, 2022
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signallingLyra O Randzavola, Paige M Mortimer, Emma Garside, et al.
Journal of Geophysical Research. Atmospheres : JGR|September 10, 2016
Effect of dimethylamine on the gas phase sulfuric acid concentration measured by Chemical Ionization Mass SpectrometryL Rondo, S Ehrhart, A Kürten, et al.
JAMA|November 17, 2023
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical TrialThomas G Stewart, Paulina A Rebolledo, Ahmad Mourad, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
JAMA Network Open|October 18, 2024
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
Cancer Research|September 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor ResistanceMandy Lawson, Natalie Cureton, Susana Ros, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Plos Biology|August 29, 2006
Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryoteJonathan A Eisen, Robert S Coyne, Martin Wu, et al.
Pageof 83

Showing results (811-820 of 822) with videos related to

Sort By:
Pageof 83
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trialAhmad Mourad, Gregory A Grandits, Lianne K Siegel, et al.
Plos Biology|April 7, 2021
Neural stem cells traffic functional mitochondria via extracellular vesiclesLuca Peruzzotti-Jametti, Joshua D Bernstock, Cory M Willis, et al.
Elife|November 24, 2022
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signallingLyra O Randzavola, Paige M Mortimer, Emma Garside, et al.
Journal of Geophysical Research. Atmospheres : JGR|September 10, 2016
Effect of dimethylamine on the gas phase sulfuric acid concentration measured by Chemical Ionization Mass SpectrometryL Rondo, S Ehrhart, A Kürten, et al.
JAMA|November 17, 2023
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical TrialThomas G Stewart, Paulina A Rebolledo, Ahmad Mourad, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
JAMA Network Open|October 18, 2024
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical TrialRussell L Rothman, Thomas G Stewart, Ahmad Mourad, et al.
Cancer Research|September 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor ResistanceMandy Lawson, Natalie Cureton, Susana Ros, et al.
Plos One|February 14, 2017
Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASEmily Saintas, Liam Abrahams, Gulshan T Ahmad, et al.
Plos Biology|August 29, 2006
Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryoteJonathan A Eisen, Robert S Coyne, Martin Wu, et al.
Pageof 83